Company intelligence / Profile preview

StimGuard

Fort Lauderdale, Florida, United States

Ownership: Private
Employees: ~11
Development stage: Other

Overview

StimGuard was a private U.S. medical device company developing wirelessly powered, injectable microtechnology neurostimulators for urologic disorders. The company focused primarily on minimally invasive tibial nerve stimulation for overactive bladder, with its lead product Protect PNS positioned as an office-based, drug-free neuromodulation therapy. In April 2020, StimGuard changed its corporate name to Micron Medical as it prepared for commercialization. In July 2021, Uro Medical acquired Micron Medical’s urology-based assets, including the Protect PNS program and related clinical studies. As a result, StimGuard no longer appears to operate as an independent company.

Therapeutic areas: UrologyNephrology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on StimGuard.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on StimGuard.

Explore the full profile